Everything below concerns REV-ERB agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-16. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
To get fair wages beyond the national minimum wage, and award wage scales, unions and employers may collectively bargain. Unlike most wealthy OECD countries, Australia's collective bargaining system is largely confined to individual enterprises, rather than multi-employer bargaining. Combined with weak protections for union organising, this means that coverage of collective agreements was just 15% in 2022, compared to coverages typically over 80% in wealthier European Union member states that promote sectoral collective bargaining. Under the Fair Work Act 2009 sections 247–252, the Fair Work Commission may authorise "single interest employers" to bargain, which can include a corporate group, or multiple entities in a joint venture or common enterprise, but usually separate organisations bargain separately, if at all. Under section 186, the FWC may approve multi-employer agreements, but must find that the "agreement has been genuinely agreed to by each employer" with "no person coerced", even though solidarity strike action is unlawful in Australia. This makes multi-employer agreements rare and the coverage for fair wage agreements historically low. Employees of several employers may also ask the FWC for a special "low-paid bargaining" authorisation under sections 241 to 246, if worker pay is particularly bad and bargaining power weak, but even then employees do not have a right to take collective action. Under sections 260–265, the FWC may make a low pay determination if bargaining does not work, but in practice no multi-employer agreements have resulted.
=== P53 and p73 === p53 and p73 are tumor suppressor proteins and their degradation is tightly regulated by ubiquitination. Recently it was shown that their degradation can also occur via an ubiquitin-independent process; NQO1 blocks p53 and p73 degradation in the presence of NADH and protects them from 20S proteasomal degradation. This protein-protein interaction between p53 and NQO1 was non-catalytic.
On 17 September, at least 12 people were killed and more than 2,750 were wounded, including Hezbollah members and civilians, after the explosions of their pagers in Lebanon and Syria, including in Beirut. The attack resulted in 1,500 fighters being taken out of action, with many facing blindness or losing their hands. Among those injured was the Iranian ambassador, Mojtaba Amani. Several drones launched from Lebanon crossed the border. Hezbollah confirmed the death of 12 militants on that day. Also on 17 September, the Shin Bet claimed that it thwarted a Hezbollah attempt for assassinate a former senior defence official with a Claymore mine. On 18 September another series of explosions involving wireless devices was reported across Lebanon, killing at least 30 people and injuring 750 others. Hezbollah said that it carried out four strikes targeting IDF sites including in Neve Ziv and Beit Hillel with rockets and artillery. Lebanese media reported that Israeli strikes struck Al-Jbeen, Shama, Majdal Zoun, Kfar Kila, Kfar Shiuba, Houla, al-Taybeh, the forest in the vicinity of Kounine and Beit Yahoun, and the outskirts of Yater. The IDF said that it struck Hezbollah sites in Chihine, Tayibe, Blida, Meiss El Jabal, Aitaroun and Kfarkela and a Hezbollah weapons depot in Khiam in these airstrikes. On 19 September, the IDF said that it started carrying out airstrikes against Hezbollah to destroy its capabilities in southern Lebanon while heavy bombing was reported in Deir Qanoun En Nahr.
== Classification == Classification of radioactive waste varies by country. The IAEA, which publishes the Radioactive Waste Safety Standards (RADWASS), also plays a significant role. The proportion (by volume) of various types of waste generated in the UK are:
=== Final tour and death in New York === Thomas left Laugharne on 9 October 1953 on the first leg of his fourth trip to America. He called on his mother, Florence, to say goodbye: "He always felt that he had to get out from this country because of his chest being so bad." Thomas had suffered from chest problems for most of his life, though they began in earnest soon after he moved in May 1949 to the Boat House at Laugharne—the "bronchial heronry", as he called it. Within weeks of moving in, he visited a local doctor, who prescribed medicine for both his chest and throat. While waiting in London before his flight, Thomas stayed with the comedian Harry Locke and worked on Under Milk Wood. Locke noted that Thomas was having trouble with his chest, "terrible" coughing fits that made him go purple in the face. He was also using an inhaler to help his breathing. There were reports, too, that Thomas was also having blackouts. His visit to the BBC producer Philip Burton, a few days before he left for New York, was interrupted by a blackout. On his last night in London, he had another in the company of his fellow poet Louis MacNeice. Thomas arrived in New York on 20 October 1953 to undertake further performances of Under Milk Wood, organised by John Brinnin, his American agent and Director of the Poetry Centre. Brinnin did not travel to New York but remained in Boston to write. He handed responsibility to his assistant, Liz Reitell. She met Thomas at Idlewild Airport and was shocked at his appearance.
Sources: en.wikipedia.org
=== Evermont: The Royal Rumble === First aired: 2 December 2010 Meet Evermont, a wannabe rapper who says he can "smell the bitch" in his victims. He calls himself "the king" and makes life miserable for Jesse and Colton. Mayhem Miller brings in professional MMA Brazilian jiu-jitsu fighter Bobby "King" Green who has a record of 14 wins and 3 losses to put Evermont in his place. In the first round, Bobby Green made him tap out five times. In the second round, Evermont got scared and didn't continue into the second round. He was the second bully to withdraw from the second round, the first being Emil. Jesse and Colton won $10,000.
Unallocated input satoshis in the transaction become the transaction fee. Losing a private key means losing access to the bitcoins, with no other proof of ownership accepted by the protocol. For instance, in 2013, a user lost ₿7,500, valued at US$7.5 million, by accidentally discarding a hard drive with the private key. It is estimated that around 20% of all bitcoins are lost. The private key must also be kept secret as its exposure, such as through a data breach, can lead to theft of the associated bitcoins. As of December 2017, approximately ₿980,000 had been stolen from cryptocurrency exchanges.
American Kestrel Partnership, The Peregrine Fund Research and conservation activities designed for participants of all ages KestrelCams, American Kestrel Partnership, The Peregrine Fund Live, streaming video of a nesting kestrel pair Photos, audio and video of American kestrel from Cornell Lab of Ornithology's Macaulay Library American Kestrel – Falco sparverius – USGS Patuxent Bird Identification InfoCenter American Kestrel photo gallery at VIREO (Drexel University)
I’ve always been a fan of much of the earliest electronic music. I’d say obviously from that era Brian Eno, Tangerine Dream, Synergy, Isao Tomita and Vangelis all influenced me. When I was growing up in New Zealand, I remember seeing a BBC clip of Emerson Lake and Palmer performing “Fanfare for the Common Man”. I just thought that huge analog synth looming over Emerson looked and sounded so cool -- I was hooked. I still find something totally unique about the sonic textures many of the early synth pioneers were able to create. At a time when a polyphonic synth setup could cost as much as several houses, I think it influenced the amount of time and thought invested in crafting unique sounds. On the defunct Half-Life website, his function was described as follows: "Kelly did all of the music and sound effects for Half-Life, and wrote sound code to create character speech and DSP reverb effects." On Valve's official website circa 1998, his function was described as follows: "Kelly, formerly a product unit manager at Microsoft, has a programming background that includes consumer multimedia, database engines, and networking. He created all the music and sound effects for Half-Life." As also stated on the website, he was the lead singer for the Seattle based band: Lucy's Fishing Trip In addition to composing the soundtrack for Half-Life 2, Bailey was one of four Valve employees – the others being David Speyrer, Eric Kirchmer, and Greg Coomer – who served as facial models for Gordon Freeman's face in the game's promotional materials.
Certain progestins, namely cyproterone acetate and medroxyprogesterone acetate and as described previously, are used at high doses as functional antiandrogens due to their antigonadotropic effects to help suppress testosterone levels in transgender women. Aside from the specific use of testosterone suppression however, there are no other indications of progestogens in transgender women at present. In relation to this, the use of progestogens in transgender women is controversial, and they are not otherwise routinely prescribed or recommended. Besides progesterone, cyproterone acetate, and medroxyprogesterone acetate, other progestogens that have been reported to have been used in transgender women include hydroxyprogesterone caproate, dydrogesterone, norethisterone acetate, and drospirenone. Progestins in general largely have the same progestogenic effects however, and in theory, any progestin could be used in transgender women. Clinical research on the use of progestogens in transgender women is very limited. Some patients and clinicians believe, on the basis of anecdotal and subjective claims, that progestogens may provide benefits such as improved breast and/or nipple development, mood, and libido in transgender women. There are no clinical studies to support such reports at present. No clinical study has assessed the use of progesterone in transgender women, and only a couple of studies have compared the use of progestins (specifically cyproterone acetate and medroxyprogesterone acetate) versus the use of no progestogen in transgender women.
Sources: en.wikipedia.org
=== Library === Bromley has a central library in the same building as the Churchill Theatre with a large book stock, Internet and wifi access, reference library and local studies department. It functions as the central library of the broader Bromley Borough Libraries Service, but is scheduled to be moved to another location on Bromley High Street as part of a major redevelopment. The new location is planned to open in 2026 with dedicated study and meeting areas and expanded children’s spaces. Other smaller libraries include the Burnt Ash Library, near the Sundridge Park area of Bromley, which was refurbished and reopened in February 2025 with improved lighting, accessible toilets, a better children’s area, and a new heating system as part of the borough’s wider library upgrade programme.
Takamine Tokumei from Shuri, Ryūkyū Kingdom, is reported to have made a general anesthesia in 1689 in the Ryukyus, now known as Okinawa. He passed on his knowledge to the Satsuma doctors in 1690 and to Ryūkyūan doctors in 1714. Hanaoka Seishū (華岡 青洲, 1760–1835) of Osaka was a Japanese surgeon of the Edo period with a knowledge of Chinese herbal medicine, as well as Western surgical techniques he had learned through Rangaku (literally "Dutch learning", and by extension "Western learning"). Beginning in about 1785, Hanaoka embarked on a quest to re-create a compound that would have pharmacologic properties similar to Hua Tuo's mafeisan. After years of research and experimentation, he finally developed a formula which he named tsūsensan (also known as mafutsu-san). Like that of Hua Tuo, this compound was composed of extracts of several different plants, including:
According to Adorno's translator Robert Hullot-Kentor, the central motive of Adorno's work thus consists in determining "how life could be more than the struggle for self-preservation." In this sense, the principle of self-preservation, Adorno writes in Negative Dialectics, is nothing but "the law of doom thus far obeyed by history." At its most basic, Adorno's thought is motivated by a fundamental critique of this law. Adorno was chiefly influenced by Max Weber's critique of disenchantment, György Lukács's Hegelian interpretation of Marxism, and Walter Benjamin's philosophy of history. Adorno, along with the other major Frankfurt School theorists, Max Horkheimer and Herbert Marcuse, argued that advanced capitalism had managed to contain or liquidate the forces that would bring about its collapse and that the revolutionary moment, when it would have been possible to transform it into socialism, had passed. As he put it at the beginning of his Negative Dialectics (1966), philosophy is still necessary because the time to realize it has been missed. Adorno argued that capitalism had become more entrenched by attacking the objective basis of revolutionary consciousness and liquidating the individualism that had underpinned critical consciousness. Adorno, as well as Horkheimer, critiqued all forms of positivism as responsible for technocracy and disenchantment and sought to produce a theory that both rejected positivism and avoided reinstating traditional metaphysics.
==== Vitamin E ==== Vitamin E is the collective name for a set of eight related tocopherols and tocotrienols, which are fat-soluble vitamins with antioxidant properties. Of these, α-tocopherol has been most studied as it has the highest bioavailability, with the body preferentially absorbing and metabolising this form. Alpha-tocopherol is the lipid-soluble antioxidant that protects membranes from oxidation by reacting with lipid radicals produced in the lipid peroxidation chain reaction. This removes the free radical intermediates and prevents the propagation reaction from continuing. This reaction produces oxidized α-tocopheroxyl radicals that can be recycled back to the active reduced form by other antioxidants, such as ascorbate. The functions of the other forms of vitamin E are less well understood, although γ-tocopherol is a nucleophile that may react with electrophilic mutagens, and tocotrienols may be important in protecting neurons from damage.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.